ScripSun Pharmaceutical Industries sees “good” opportunities for Antibe Therapeutics Inc’s lead investigational drug, otenaproxesul, both in the US and emerging markets if all goes to plan amid wider conce
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Genexine, KGBio Ink $1.1bn License Pact
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
ScripThe progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer